Quick Answer
Stemtech Corp reported Diluted EPS of $0.03 per share (loss) for fiscal year 2024.
Stemtech Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$0.03 | +57.1% |
| 2023 | -$0.07 | +63.2% |
| 2022 | -$0.19 | +5.0% |
| 2021 | -$0.20 | -100.0% |
| 2020 | -$0.10 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.01 | +0.0% | — |
| June 30, 2025 | $0.00 | +100.0% | +100.0% |
| March 31, 2025 | -$0.01 | +50.0% | +0.0% |
| September 30, 2024 | -$0.01 | +0.0% | +0.0% |
| June 30, 2024 | -$0.01 | — | +50.0% |
| March 31, 2024 | -$0.02 | +50.0% | -100.0% |
| September 30, 2023 | -$0.01 | -102.6% | — |
| June 30, 2023 | $0.00 | +100.0% | +100.0% |
- Stemtech Corp showed an increase of +57.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2024 period, Stemtech Corp’s diluted eps has grown by 70.0% (from $0.10 per share (loss) to $0.03 per share (loss)).
- The most recent figure is from Stemtech Corp’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: